|  Help  |  About  |  Contact Us

Publication : Mechanisms of inhibition and potentiation of α4β2 nicotinic acetylcholine receptors by members of the Ly6 protein family.

First Author  Wu M Year  2015
Journal  J Biol Chem Volume  290
Issue  40 Pages  24509-18
PubMed ID  26276394 Mgi Jnum  J:225865
Mgi Id  MGI:5694852 Doi  10.1074/jbc.M115.647248
Citation  Wu M, et al. (2015) Mechanisms of Inhibition and Potentiation of alpha4beta2 Nicotinic Acetylcholine Receptors by Members of the Ly6 Protein Family. J Biol Chem 290(40):24509-18
abstractText  alpha4beta2 nicotinic acetylcholine receptors (nAChRs) are abundantly expressed throughout the central nervous system and are thought to be the primary target of nicotine, the main addictive substance in cigarette smoking. Understanding the mechanisms by which these receptors are regulated may assist in developing compounds to selectively interfere with nicotine addiction. Here we report previously unrecognized modulatory properties of members of the Ly6 protein family on alpha4beta2 nAChRs. Using a FRET-based Ca(2+) flux assay, we found that the maximum response of alpha4beta2 receptors to agonist was strongly inhibited by Ly6h and Lynx2 but potentiated by Ly6g6e. The mechanisms underlying these opposing effects appear to be fundamentally distinct. Receptor inhibition by Lynx2 was accompanied by suppression of alpha4beta2 expression at the cell surface, even when assays were preceded by chronic exposure of cells to an established chaperone, nicotine. Receptor inhibition by Lynx2 also was resistant to pretreatment with extracellular phospholipase C, which cleaves lipid moieties like those that attach Ly6 proteins to the plasma membrane. In contrast, potentiation of alpha4beta2 activity by Ly6g6e was readily reversible by pretreatment with phospholipase C. Potentiation was also accompanied by slowing of receptor desensitization and an increase in peak currents. Collectively our data support roles for Lynx2 and Ly6g6e in intracellular trafficking and allosteric potentiation of alpha4beta2 nAChRs, respectively.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

13 Bio Entities

Trail: Publication

0 Expression